Highlights Pharmala Biotech Holdings Inc.

Equities

MDMA

CA71719L1067

Market Closed - Canadian Securities Exchange Other stock markets 03:55:28 2024-07-04 pm EDT			5-day change	1st Jan Change
0.11 ^CAD	0.00%		-12.00%	-21.43%

May. 03	PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy	MT
Apr. 23	Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy	May. 03	MT
Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla	Apr. 23	CI
Pharmala Biotech Completes $750,000 Private Placement, Debt Settlement	Apr. 19	MT
PharmAla Biotech Provides Australian Update	Apr. 05	MT
Pharmala Biotech Holdings Inc. Allowance Granted for Ala-002 Composition by US Patent and Trademark Office	Mar. 27	CI
Pharmala Biotech Holdings Inc. Signs Sale Agreement with Numinus	Mar. 26	CI
PharmAla Says Patent Allowance Granted for P-1 Molecule by USPTO	Mar. 20	MT
Pharmala Biotech Holdings Inc. Announces Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office	Mar. 20	CI
PharmAla Biotech Holdings Inc. Announces Joint Venture with Cortexa Pty. Ltd	Mar. 18	CI
PharmAla Biotech Holdings Inc. Announces Data from its Computational Drug Discovery Program in the Scientific Journal ACS Chemical Neuroscience	Feb. 20	CI
Listed Duo PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development	Feb. 09	MT
PharmAla Biotech Holdings Inc. Enters into Consulting Relationship with Red Light Holland Corp	Feb. 09	CI
PharmAla Reports Q1 Profit, Provides Business Update	Jan. 31	MT
PharmAla up 41%, Granted Controlled Drugs & Substances Dealer's License by Health Canada	Jan. 25	MT
Pharmala Biotech Holdings Inc.'s PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance	Jan. 08	CI
PharmAla Biotech Holdings Inc. Announces World's First Observational Trial to Assess Real-World Efficacy of MDMA Treatment	Nov. 09	CI
PharmAla Biotech Received First Office Action for PharmAla-1 PCT Filing	23-09-25	MT
Pharmala Biotech Holdings Inc. Receives First Office Action for PharmAla-1 Pct Filing	23-09-25	CI
PharmAla Biotech Holdings Inc. Ships GMP LaNeo Efficacy to Mind Medicine Australia	23-08-10	CI
PharmAla Biotech Filed Patent for Novel MDXX Molecule PharmAla-1	23-07-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pharmala Biotech Holdings Inc.

Equities

MDMA

CA71719L1067

Highlights

Filters